Changing the Health Behavior of Patients With Cardiovascular Disease Through an Electronic Health Intervention in Three Different Countries: Cost-Effectiveness Study in the Do Cardiac Health: Advanced New Generation Ecosystem (Do CHANGE) 2 Randomized Controlled Trial (Preprint)
Authors:
- Jordi Piera-JiménezJPJordi Piera-Jiménez
- Marjolein WintersMWMarjolein Winters
- Eva BroersEBEva Broers
- Damià Valero-BoverDVDamià Valero-Bover
- Mirela HabibovicMHMirela Habibovic
- Jos W M G WiddershovenJWJos W M G Widdershoven
- Frans FolkvordFFFrans Folkvord
- Francisco Lupiáñez-VillanuevaFLFrancisco Lupiáñez-Villanueva
Preprint
- 9 December 2019
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND During the last few decades, preventing the development of cardiovascular disease has become a mainstay for reducing cardiovascular morbidity and mortality. It has been suggested that interventions should focus more on committed approaches of self-care, such as electronic health techniques. OBJECTIVE This study aimed to provide evidence to understand the financial consequences of implementing the “Do Cardiac Health: Advanced New Generation Ecosystem” (Do CHANGE 2) intervention, which was evaluated in a multisite randomized controlled trial to change the health behavior of patients with cardiovascular disease. METHODS The cost-effectiveness analysis of the Do CHANGE 2 intervention was performed with the Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing tool, based on a Markov model of five health states. The following two types of costs were considered for both study groups: (1) health care costs (ie, costs associated with the time spent by health care professionals on service provision, including consultations, and associated unplanned hospitalizations, etc) and (2) societal costs (ie, costs attributed to the time spent by patients and informal caregivers on care activities). RESULTS The Do CHANGE 2 intervention was less costly in Spain (incremental cost was −€2514.90) and more costly in the Netherlands and Taiwan (incremental costs were €1373.59 and €1062.54, respectively). Compared with treatment as usual, the effectiveness of the Do CHANGE 2 program in terms of an increase in quality-adjusted life-year gains was slightly higher in the Netherlands and lower in Spain and Taiwan. CONCLUSIONS In general, we found that the incremental cost-effectiveness ratio strongly varied depending on the country where the intervention was applied. The Do CHANGE 2 intervention showed a positive cost-effectiveness ratio only when implemented in Spain, indicating that it saved financial costs in relation to the effect of the intervention. CLINICALTRIAL ClinicalTrials.gov NCT03178305; https://clinicaltrials.gov/ct2/show/NCT03178305Keywords
All Related Versions
- Published version: Journal of Medical Internet Research, 22 (7), e17351.
This publication has 29 references indexed in Scilit:
- Usefulness of a Lifestyle Intervention in Patients With Cardiovascular DiseaseThe American Journal of Cardiology, 2020
- Connected Health in Hypertension ManagementFrontiers in Cardiovascular Medicine, 2019
- Health Lifestyle Data-Driven Applications Using Pervasive Computing2019
- Effectiveness of the mHealth technology in improvement of healthy behaviors in an elderly population—a systematic reviewmHealth, 2017
- Self‐Care for the Prevention and Management of Cardiovascular Disease and StrokeJournal of the American Heart Association, 2017
- 2016 European Guidelines on cardiovascular disease prevention in clinical practicePolish Heart Journal, 2016
- Telemedicine for cardiovascular disease continuum: A position paper from the Italian Society of Cardiology Working Group on Telecardiology and InformaticsInternational Journal of Cardiology, 2015
- Personal health technology: A new era in cardiovascular disease preventionPostgraduate Medicine, 2015
- Mediators and moderators of behavior change in patients with chronic cardiopulmonary disease: the impact of positive affect and self-affirmationTranslational Behavioral Medicine, 2013
- Negotiating the coresearcher mandate – service users’ experiences of doing collaborative research on mental healthDisability and Rehabilitation, 2012